ArticleBiomedical reports2015

Bortezomib and belinostat inhibit renal cancer growth synergistically by causing ubiquitinated protein accumulation and endoplasmic reticulum stress.

Takako Asano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.